Stocktoria
FITLIFE BRANDS, INC. FTLF
Nasdaq · XNAS · stock · Medicinal Chemicals & Botanical Products · website · IPO 2007-10-26
FITLIFE BRANDS, INC. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Lingenbrink Matthew | director | 2026-04-10 | Buy | 3,000 | $9.76 |
| Dawson Grant Robert | director | 2026-04-10 | Buy | 3,000 | $9.98 |
| Yakatan Seth | director | 2026-01-15 | Buy | 164 | $15.36 |
| Ordal Todd | director | 2025-04-15 | Buy | 300 | $12.07 |
| Lingenbrink Matthew | director | 2025-04-14 | Buy | 3,000 | $12.17 |
| Lingenbrink Matthew | director | 2025-03-31 | Buy | 2,800 | $12.17 |
| Dayton Judd | CHIEF EXECUTIVE OFFICER | 2025-03-31 | Option exercise | 144,000 | $2.62 |
| Dawson Grant Robert | director | 2025-03-28 | Grant | 2,144 | $12.68 |
Source: SEC EDGAR filings · CIK 0001374328 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.